產品編號
1530632
CAS 號
159351-69-6
中文名稱
依維莫司 (依維莫司)
MDL 號
MFCD00929329
分子量
958.22
存儲條件
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
沸點
998.7±75.0 °C at 760 mmHg
閃點
旋光
描述
TPSA
204.66
LogP
6.1972
H_Acceptors
14
H_Donors
3
Rotatable_Bonds
9
[1]. A O Ferreiro, et al. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series. Transplant Proc. 2014 Dec;46(10):3496-501.
[2]. Aleksandra Kezic, et al. Effects of everolimus on oxidative stress in kidney model of ischemia/reperfusion injury. Am J Nephrol. 2013;37(4):291-301.
[3]. Chang-Kwon Oh, et al. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. Transplantation. 2015 Jan;99(1):180-6.
[4]. Daniel J Inglis, et al. The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer. Cancer Biol Ther. 2014;15(11):1552-60.
[5]. Dorien Van den Bossche, et al. Deproteination of whole blood for LC-MS/MS using paramagnetic micro-particles. Clin Biochem. 2014 Oct;47(15):112-5.
警示圖
警示詞
Warning
危險申明
H351-H361-H373-H410
警告申明
P260-P273-P280-P391-P405-P501
GHS 編碼
GHS08,GHS09
危險類別
9
UN 編碼
3077
包裝等級
Ⅲ
現貨供應
專業護航
售后無憂
品質保障
無需湊單